Related Experiment Video
Updated: Jun 4, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Synergism between outer membrane proteins and antimicrobials.
P Veiga-Crespo1, E Fusté, T Vinuesa
1Department of Microbiology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, CP15782 Santiago de Compostela La Coruña, Spain.
Antimicrobial Agents and Chemotherapy
|February 16, 2011
Summary
Exogenous porins enhance antibiotic effectiveness against Gram-negative bacteria, offering a novel strategy to combat rising antibiotic resistance. Combining porins with antibiotics shows greater bactericidal effects than either agent alone.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Antibiotic resistance is a growing global health crisis due to increasing resistant strains and limited new antimicrobial development.
- Gram-negative bacteria possess an outer membrane (OM) that acts as a permeability barrier, reducing susceptibility to many antibiotics.
- Porins, proteins forming channels in the OM, are crucial for the transport of hydrophilic molecules into Gram-negative bacteria.
Purpose of the Study:
- To investigate the potential of using exogenous porins to enhance the efficacy of conventional antibiotics against Gram-negative bacteria.
- To determine if porins can reduce the required concentrations of antibiotics like ampicillin, ciprofloxacin, cefotaxime, clindamycin, erythromycin, and tetracycline.
- To evaluate the combined bactericidal effects of antibiotics and porins compared to their individual activities.
Main Methods:
- Utilizing exogenous porins in combination with various antibiotics (ampicillin, ciprofloxacin, cefotaxime, clindamycin, erythromycin, tetracycline).
- Testing the bactericidal activity of these combinations on Escherichia coli cultures, particularly during the logarithmic growth phase.
- Analyzing the synergistic or additive effects of antibiotic-porin mixtures.
Main Results:
- Exogenous porins demonstrated a bactericidal effect on Escherichia coli, especially when combined with low antibiotic concentrations.
- Antibiotic-porin mixtures exhibited significantly greater bactericidal effects than either antibiotics or porins used alone.
- Observed variations in efficacy depending on the specific antibiotic used in combination with porins.
Conclusions:
- Exogenous porins represent a promising strategy to overcome the outer membrane barrier in Gram-negative bacteria.
- Combining porins with existing antibiotics can enhance their bactericidal activity and potentially reduce required dosages.
- This approach offers a novel avenue for developing alternative treatments against antibiotic-resistant Gram-negative pathogens.
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:18Surface Membrane Barriers
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...